José A. Morais
PhD (1980) in Pharmaceutical Chemistry, University of Michigan, Ann Arbor, MI, USA
Full Professor (2000), Pharmacology
Faculdade de Farmácia, Universidade de Lisboa — Av. Prof. Gama Pinto, 1649-003 Lisboa, Portugal
His scientific areas of research interest are varied and include Absorption Pharmacokinetics: Bioavailability/ Bioequivalence; Therapeutic Drug Monitoring (TDM), Population Pharmacokinetics, Basic Pharmacokinetics, including modelling and simulation, Medicines Quality Control, Bioanalytical Methodology and Pharmaceutical Technology, especially Novel Drug Delivery Systems. He has been invited speaker in ca. 120 conferences and 150 communications in scientific meetings, co-authored more than 60 scientific articles, participated in the organisation of ca. 60 scientific meetings and supervised 11 Master and 17 PhD theses. He’s focusing now on in silico prediction of pharmacokinetic characteristics, and in vitro models of drug absorption
Margarida Estudante, José A. G. Morais, Graça Soveral, Leslie Z. Benet. Intestinal drug transporters: An overview. Adv Drug Deliv Rev 2013; 65:1340-56
Paulo Paixão, Luís F. Gouveia, José A. G. Morais. An alternative single dose parameter to avoid the need for steady-state studies on oral extended-release drug products. Eur J Pharm Biopharm 2012; 80 (2): 410-7; (Outstanding Manuscript Award by the American Association of Pharmaceutical Scientists, Chicago, 13 October, 2012).
Manuela Carvalheiro, João Jorge, Carla Eleutério, Ana F. Pinhal, Ana C. Sousa José A. G. Morais, M. Eugénia M. Cruz, Trifluralin liposomal formulations active against Leishmania donovani infections. Eur J Pharm Biopharm, 2009; 71: 292–6.
A. Moreira, R. Lobato, J. Morais, S. D. Silva, J. Ribeiro, A. Figueira, A. Fernandes, J. Oliveira, J. L. Passos-Coelho. Influence of the Interval Between the Administration of Doxorubicin and Paclitaxel on the Pharmacokinetics of these Drugs in Patients with Locally Advanced Breast Cancer. Cancer Chemother Pharmacol 2001; 48:333-7.
José A. Morais and John G. Wagner. A model describing the disposition of phenytoin in isolated rat hepatocytes”. Biopharm Drug Dispos 1984; 5:357-76.